BioMedica Cazin - TUMORSKI MARKERI Na skali uzroka smrtnosti, tumori zauzimaju, visoko treće mjesto. Kako se još uvijek u velikoj mjeri radi o neizlječivim bolestima, naročito u slučajevima zakašnjele dijagnoze, razumljive su
![Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration | BMC Medicine | Full Text Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration | BMC Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1741-7015-10-51/MediaObjects/12916_2011_Article_528_Fig2_HTML.jpg)
Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration | BMC Medicine | Full Text
![Cancers | Free Full-Text | V-Domain Ig Suppressor of T Cell Activation (VISTA) Expression Is an Independent Prognostic Factor in Multiple Myeloma | HTML Cancers | Free Full-Text | V-Domain Ig Suppressor of T Cell Activation (VISTA) Expression Is an Independent Prognostic Factor in Multiple Myeloma | HTML](https://www.mdpi.com/cancers/cancers-13-02219/article_deploy/html/images/cancers-13-02219-g006.png)
Cancers | Free Full-Text | V-Domain Ig Suppressor of T Cell Activation (VISTA) Expression Is an Independent Prognostic Factor in Multiple Myeloma | HTML
![Cancers | Free Full-Text | Tumor-Targeted Drug Conjugates as an Emerging Novel Therapeutic Approach in Small Cell Lung Cancer (SCLC) | HTML Cancers | Free Full-Text | Tumor-Targeted Drug Conjugates as an Emerging Novel Therapeutic Approach in Small Cell Lung Cancer (SCLC) | HTML](https://www.mdpi.com/cancers/cancers-11-01297/article_deploy/html/images/cancers-11-01297-g001.png)
Cancers | Free Full-Text | Tumor-Targeted Drug Conjugates as an Emerging Novel Therapeutic Approach in Small Cell Lung Cancer (SCLC) | HTML
![SVI SE BOJE LOŠE DIJAGNOZE: Šta su TUMOR MARKERI i koliko su oni zapravo pouzdani | Najnovije vesti - Srbija danas SVI SE BOJE LOŠE DIJAGNOZE: Šta su TUMOR MARKERI i koliko su oni zapravo pouzdani | Najnovije vesti - Srbija danas](https://www.srbijadanas.com/sites/default/files/styles/full_article_image/public/a/t/2020/04/26/leka.jpg)
SVI SE BOJE LOŠE DIJAGNOZE: Šta su TUMOR MARKERI i koliko su oni zapravo pouzdani | Najnovije vesti - Srbija danas
Biohem Lab - ŠTA SU TUMOR MARKERI? Tumor markeri su biološke supstance koje su prisutne u ćelijama, krvi, drugim telesnim tečnostima, kao i tumorskom tkivu osoba obolelih od karcinoma. Dokazivanje ovih supstanci
![Frontiers | The Recruitment of Neutrophils to the Tumor Microenvironment Is Regulated by Multiple Mediators | Immunology Frontiers | The Recruitment of Neutrophils to the Tumor Microenvironment Is Regulated by Multiple Mediators | Immunology](https://www.frontiersin.org/files/MyHome%20Article%20Library/734188/734188_Thumb_400.jpg)
Frontiers | The Recruitment of Neutrophils to the Tumor Microenvironment Is Regulated by Multiple Mediators | Immunology
![Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer | Journal for ImmunoTherapy of Cancer Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/9/7/e002474/F5.large.jpg)
Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer | Journal for ImmunoTherapy of Cancer
![Ablating the aryl hydrocarbon receptor (AhR) in CD11c+ cells perturbs intestinal epithelium development and intestinal immunity | Scientific Reports Ablating the aryl hydrocarbon receptor (AhR) in CD11c+ cells perturbs intestinal epithelium development and intestinal immunity | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep23820/MediaObjects/41598_2016_Article_BFsrep23820_Fig1_HTML.jpg)